Evidence map›Paper›PMID 40625223›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Multi-Region Brain Organoids Integrating Cerebral, Mid-Hindbrain, and Endothelial Systems.

Anannya Kshirsagar, Hayk Mnatsakanyan, Sai Kulkarni, John Guo, Kai Cheng, Luke Daniel Ofria, Oce Bohra, Ram Sagar, Vasiliki Mahairaki, Christian E Badr and 1 more

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Multi-Region Brain Organoids Integrating Cerebral, Mid-Hindbrain, and Endothelial Systems.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  11. Special Issue "Molecules at Play in Neurological Diseases".Current issues in molecular biology · 2025
    Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anannya KshirsagarDepartment for Biotechnology, Advanced Academic Programs, Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore, MD, 21218, USA.ORCID https://orcid.org/0009-0009-7519-3226
Hayk MnatsakanyanDepartment of Neurology, Massachusetts General Hospital, Neuroscience Program, Harvard Medical School, Boston, MA, 02129, USA.
Sai KulkarniDepartment for Biotechnology, Advanced Academic Programs, Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore, MD, 21218, USA.
John Guo7 Traits Genomics, LLC, Watertown, MA, 02472, USA.
Kai ChengDepartment of Biomedical Engineering, Whiting School of Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA.
Luke Daniel OfriaDepartment for Biotechnology, Advanced Academic Programs, Krieger School of Arts and Sciences, Johns Hopkins University, Baltimore, MD, 21218, USA.
Oce BohraDepartment of Biomedical Engineering, Whiting School of Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA.
Ram SagarDepartment of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA.
Vasiliki MahairakiDepartment of Neurology, Johns Hopkins School of Medicine, Baltimore, MD, 21205, USA.
Christian E BadrDepartment of Neurology, Massachusetts General Hospital, Neuroscience Program, Harvard Medical School, Boston, MA, 02129, USA.
Annie KathuriaDepartment of Biomedical Engineering, Whiting School of Engineering, Johns Hopkins University, Baltimore, MD, 21218, USA.ORCID https://orcid.org/0009-0000-6526-8217

Funding

Research Education ComponentP30AG066507 · NIA · JOHNS HOPKINS UNIVERSITY · PI Corinne Pettigrew · 2020 to 2026
$29.3M
Training Program in NeuroengineeringT32EB003383 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI NITISH VYOMESH THAKOR · 2004 to 2026
$6.5M
Maryland Stem Cell Research Fund 2024-MSCRFD-6379NIA NIH HHS P30 AG066507NIBIB NIH HHS T32 EB003383
6 · The paper itself

Abstract

Brain organoid technology has revolutionized the ability to model human neurodevelopment in vitro. However, current techniques remain limited by their reliance on simplified endothelial cell populations. Multi-Region Brain Organoids (MRBOs) are engineered that integrate cerebral, mid/hindbrain, and complex endothelial organoids into one structure. Unlike earlier approaches based on isolated Human Umbilical Vein Endothelial Cells, the endothelial organoids contain diverse vascular cell types, including progenitors, mature endothelial cells, pericytes, proliferating angiogenic cells, and stromal cells. The strategy employs sequential modulation of key developmental pathways to generate individual organoids, followed by optimized fusion conditions that maintain regional identities while supporting cellular integration. Single-nucleus RNA sequencing reveals that MRBOs develop discrete neural populations specific to each brain region alongside specialized endothelial populations that establish paracrine signaling networks. Integration analysis with human fetal brain data shows that MRBOs contribute to 80% of cellular clusters found in human fetal brain tissue (Carnegie stages 12-16). CellChat analysis identifies 13 previously uncharacterized endothelial-neural signaling interactions. Endothelial-derived factors are uncovered that support intermediate progenitor populations during hindbrain development, but not cerebral development, revealing a role for endothelial populations in regional brain patterning. This platform enables matching of multiple developmental regions while incorporating endothelial components, providing opportunities for studying neurodevelopmental disorders with disrupted neural-endothelial interactions.

Indexed as

BrainEndothelial CellsOrganoidsRhombencephalonHumansendothelial systemmulti‐region brain organoidneurodevelopmental processesorganoid engineering

Identifiers

PMID40625223
PMCPMC12412538

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.